Technology Council, IVD Provisions Get Go-Ahead By House/Senate Conferees
This article was originally published in The Gray Sheet
Executive Summary
A Medicare reform provision extending routine patient care coverage of breakthrough medical device trials would cost approximately $3.3 bil. less than the Congressional Budget Office originally scored, according to AdvaMed
You may also be interested in...
Diabetes, Wheelchair Firms Brace For DME Impact As Rx Bill Goes To Floor
Eleventh-hour efforts by Rep. David Hobson (R-Ohio) to craft language mitigating a reduction in payments for five DME product services appear to have fallen short, as the House and Senate prepare to begin floor debate on the Medicare bill
Diabetes, Wheelchair Firms Brace For DME Impact As Rx Bill Goes To Floor
Eleventh-hour efforts by Rep. David Hobson (R-Ohio) to craft language mitigating a reduction in payments for five DME product services appear to have fallen short, as the House and Senate prepare to begin floor debate on the Medicare bill
DME Competitive Bidding, New Tech Payments To Be Taken Up By Conferees
A provision establishing clinical trial coverage for Category A devices is part of a larger consensus reached by conferees on less controversial aspects of the "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1, S 1)